Summary of findings 2. Summary of findings: integrated community case management versus usual facility services plus CCM for malaria.
iCCM compared to usual facility services + CCM for malaria | ||||||
Patient or population: children U5 Settings: middle‐ and low‐income countries Intervention: iCCM Comparison: usual facility services + CCM for malaria | ||||||
Outcomes | Illustrative comparative risks* (95% CI) | Relative effect (95% CI) | No of participants (studies) | Certainty of the evidence (GRADE) | Narrative results | |
Assumed risk | Corresponding risk | |||||
Control (baseline risk in comparison) | iCCM (endline in intervention) | |||||
1. Coverage of appropriate treatment | ||||||
From an appropriate provider | ||||||
Any iCCM illness | 18 children U5 with any iCCM illness who received appropriate treatment from an appropriate provider, per 100 children U5 with any iCCM illness | 24 children U5 with any iCCM illness who received appropriate treatment from an appropriate provider, per 100 children U5 with any iCCM illness (22 to 25 children) | RR 1.59 (0.66 to 3.87) | 7876 children (1 CBA)a | ⊕⊝⊝⊝ Verylowb | We are uncertain of the effect of iCCM on coverage of appropriate treatment from an appropriate provider for any iCCM illness. |
2. Quality of care | ||||||
No studies reported this outcome. | We do not know the effect of iCCM on quality of care. | |||||
3. Case load or severity of illness at health facilities | ||||||
No studies reported this outcome. | We do not know the effect of iCCM on case load or severity of illness at health facilities. | |||||
4. Mortality | ||||||
No studies reported this outcome. | We do not know the effect of iCCM on mortality. | |||||
5. Adverse events | ||||||
No studies reported this outcome. | We do not know the effect of iCCM on adverse events. | |||||
6. Coverage of careseeking | ||||||
To an appropriate provider of treatment services | ||||||
Any iCCM illness | 66 children U5 with any iCCM illness for whom care was sought from an appropriate provider, per 100 children U5 with any iCCM illness | 70 children U5 with any iCCM illness for whom care was sought from an appropriate provider, per 100 children U5 with any iCCM illness (65 to 74 children) | RR 1.21 (0.90 to 1.62) | 811 children (1 cRCT)c | ⊕⊕⊝⊝ Lowd | iCCM may have little or no effect on careseeking to an appropriate provider of treatment services for any iCCM illness. |
*The basis for the assumed risk is the control group risk across studies (number of events in control group across studies / total in control group across studies). The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CBA: controlled before‐after study; CCM: community case management; CI: confidence interval; cRCT: cluster‐randomized controlled trial; iCCM: integrated community case management; RR: risk ratio; U5: aged under‐five years. | ||||||
GRADE Working Group grades of evidence High certainty: This research provides a very good indication of the likely effect. The likelihood that the effect will be substantially different** is low. Moderate certainty: This research provides a good indication of the likely effect. The likelihood that the effect will be substantially different** is moderate. Low certainty: This research provides some indication of the likely effect. However, the likelihood that it will be substantially different** is high. Very low certainty: This research does not provide a reliable indication of the likely effect. The likelihood that the effect will be substantially different** is very high. ** Substantially different = a large enough difference that it might affect a decision |
aMunos 2016. bDowngraded three levels (two levels for serious risk of bias due to the study being a CBA, one level for serious imprecision). cKalyango 2012a. dDowngraded two levels. We downgraded one level for risk of bias because the primary outcome measure for Kalyango 2012a, U5 mortality, has never been published – indicating risk of reporting bias for this study. We downgraded one level for indirectness due to the effect being based on a single cluster‐randomized controlled trial.